Herantis Pharma Plc – allocation of option rights
Herantis Pharma Plc, Company release, 13 April 2022 at 5:35 p.m. EEST The Board of Directors of Herantis Pharma Plc ("Herantis") has on 13 April 2022 decided to grant a maximum of 168,041 option rights entitling to shares to certain members of the management team under the option rights program 2021 I. The option rights program is based on the authorization granted by the Annual General Meeting held on 15 April 2021 to issue a maximum of 975,000 option rights. The Board of Directors has in April 2021 resolved on issuance of a total of 961,221 option rights under the option rights